Previous close | 42.00 |
Open | 42.00 |
Bid | 58.05 |
Ask | 61.20 |
Strike | 45.00 |
Expiry date | 2024-06-21 |
Day's range | 42.00 - 42.00 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
Moderna is on the rise after the Food and Drug Administration delayed a decision on its RSV vaccine. But is MRNA stock, once again, a buy?
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.